Voyager Therapeutics (STU:VT6) Beginning Cash Position : €64.8 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Voyager Therapeutics Beginning Cash Position?

Voyager Therapeutics's Beginning Cash Position for the quarter that ended in Mar. 2024 was €64.8 Mil.

Voyager Therapeutics's quarterly Beginning Cash Position declined from Sep. 2023 (€230.4 Mil) to Dec. 2023 (€61.3 Mil) but then increased from Dec. 2023 (€61.3 Mil) to Mar. 2024 (€64.8 Mil).

Voyager Therapeutics's annual Beginning Cash Position increased from Dec. 2021 (€94.0 Mil) to Dec. 2022 (€112.5 Mil) but then declined from Dec. 2022 (€112.5 Mil) to Dec. 2023 (€92.1 Mil).

Voyager Therapeutics Beginning Cash Position Historical Data

The historical data trend for Voyager Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voyager Therapeutics Beginning Cash Position Chart

Voyager Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

42.83

71.33

94.00

112.54

92.14

Voyager Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															93.84	249.06	230.40	61.31	64.76

Voyager Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Voyager Therapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Voyager Therapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Voyager Therapeutics (STU:VT6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Voyager Therapeutics Inc (STU:VT6) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

VYGR:USA VT6:Germany

Address

64 Sidney Street, Cambridge, MA, USA, 02139

Website

https://www.voyagertherapeutics.com

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. The company operates in a single segment of developing and commercializing gene therapies.

Voyager Therapeutics (STU:VT6) Headlines

No Headlines